29 Nov UPDATE 1-Foundation’s cancer gene test gets U.S. FDA and Medicare nod
CHICAGO, Nov 30 (Reuters) – A test from Foundation Medicine
Inc that can detect cancer-causing mutations in 324
genes has won approval from the U.S. Food and Drug
Administration and the Center for Medicare and Medicaid
Services, the agencies said.
Inc that can detect cancer-causing mutations in 324
genes has won approval from the U.S. Food and Drug
Administration and the Center for Medicare and Medicaid
Services, the agencies said.
No Comments